NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
The emergence of widespread antimicrobial resistance has led to the need for development of novel therapeutic interventions. Antivirulence strategies are an attractive alternative to classic antimicrobial therapy; however, they require identification of new specific targets which can be exploited i...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/afb4e30e21634b5e896ebe24694c0eaa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:afb4e30e21634b5e896ebe24694c0eaa |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:afb4e30e21634b5e896ebe24694c0eaa2021-11-03T18:56:09ZNirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target2150-751110.1128/mBio.00207-21https://doaj.org/article/afb4e30e21634b5e896ebe24694c0eaa2021-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00207-21https://doaj.org/toc/2150-7511 The emergence of widespread antimicrobial resistance has led to the need for development of novel therapeutic interventions. Antivirulence strategies are an attractive alternative to classic antimicrobial therapy; however, they require identification of new specific targets which can be exploited in drug discovery programs.Samuel FennJean-Frédéric DubernCristina CiganaMaura De SimoneJames LazenbyMario JuhasStephan SchwagerIrene BianconiGerd DöringJonas ElmsleyLeo EberlPaul WilliamsAlessandra BragonziMiguel CámaraAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 2 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Microbiology QR1-502 |
spellingShingle |
Microbiology QR1-502 Samuel Fenn Jean-Frédéric Dubern Cristina Cigana Maura De Simone James Lazenby Mario Juhas Stephan Schwager Irene Bianconi Gerd Döring Jonas Elmsley Leo Eberl Paul Williams Alessandra Bragonzi Miguel Cámara NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target |
description |
The emergence of widespread antimicrobial resistance has led to the need for development of novel therapeutic interventions. Antivirulence strategies are an attractive alternative to classic antimicrobial therapy; however, they require identification of new specific targets which can be exploited in drug discovery programs. |
format |
article |
author |
Samuel Fenn Jean-Frédéric Dubern Cristina Cigana Maura De Simone James Lazenby Mario Juhas Stephan Schwager Irene Bianconi Gerd Döring Jonas Elmsley Leo Eberl Paul Williams Alessandra Bragonzi Miguel Cámara |
author_facet |
Samuel Fenn Jean-Frédéric Dubern Cristina Cigana Maura De Simone James Lazenby Mario Juhas Stephan Schwager Irene Bianconi Gerd Döring Jonas Elmsley Leo Eberl Paul Williams Alessandra Bragonzi Miguel Cámara |
author_sort |
Samuel Fenn |
title |
NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target |
title_short |
NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target |
title_full |
NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target |
title_fullStr |
NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target |
title_full_unstemmed |
NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target |
title_sort |
nira is an alternative nitrite reductase from pseudomonas aeruginosa with potential as an antivirulence target |
publisher |
American Society for Microbiology |
publishDate |
2021 |
url |
https://doaj.org/article/afb4e30e21634b5e896ebe24694c0eaa |
work_keys_str_mv |
AT samuelfenn niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT jeanfredericdubern niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT cristinacigana niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT mauradesimone niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT jameslazenby niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT mariojuhas niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT stephanschwager niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT irenebianconi niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT gerddoring niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT jonaselmsley niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT leoeberl niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT paulwilliams niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT alessandrabragonzi niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget AT miguelcamara niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget |
_version_ |
1718445478536806400 |